2
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Prostatic Neoplasms
18
Neoplasms
14
Breast Neoplasms
13
Neuroendocrine Tumors
9
Lung Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Neoplasm Metastasis
6
Stomach Neoplasms
5
Esophageal Neoplasms
5
Uterine Cervical Neoplasms
4
Pancreatic Neoplasms
4
Multiple Myeloma
4
Disease
4
Urinary Bladder Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Rectal Neoplasms
3
Mouth Neoplasms
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Head and Neck Neoplasms
3
Glioma
3
Esophageal Squamous Cell Carcinoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplastic Cells, Circulating
2
Nasopharyngeal Carcinoma
2
Multiple Pulmonary Nodules
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Liver Neoplasms
2
Leukemia
2
Interventions
Doxorubicin
17
Echocardiography
14
Cyclophosphamide
9
Trastuzumab
8
Exercise
8
Dexrazoxane
8
Electrocardiography
7
Razoxane
6
Carvedilol
6
Vincristine
4
Radiotherapy
4
Filgrastim
4
Docetaxel
4
Methotrexate
3
Granulocyte Colony-Stimulating Factor
3
Etoposide
3
Cisplatin
3
Atorvastatin
3
salicylhydroxamic acid
2
sacubitril and valsartan sodium hydrate drug combination
2
empagliflozin
2
dapagliflozin
2
Tablets
2
Social Determinants of Health
2
Silymarin
2
Prednisone
2
Paclitaxel
2
Neoadjuvant Therapy
2
Magnetic Resonance Spectroscopy
2
Leucovorin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Positron Emission Tomography Computed Tomography
×
Clear all
NCT06597045
2024-09-19
BIOCAPRI
NHS Greater Glasgow and Clyde
Active not recruiting
60 enrolled